The Essential Strategies to Mitigate Cardiotoxicity Caused by Doxorubicin

The Essential Strategies to Mitigate Cardiotoxicity Caused by Doxorubicin

The study of mechanisms underlying cardiotoxicity of doxorubicin and the development of strategies to mitigate doxorubicin-induced cardiotoxicity are the most relevant issues of modern cardio-oncology. This is due to the high prevalence of cancer in the population and the need for frequent use of hi...

Full description

Bibliographic Details
Main Author:	Aleksey Michailovich Chaulin
Format:	Article
Language:	English
Published:	MDPI AG 2023-10-01
Series:	Life
Subjects:	cardiotoxicity doxorubicin risk factors cardiovascular risk cardiovascular diseases cardioprotection strategies
Online Access:	https://www.mdpi.com/2075-1729/13/11/2148

Similar Items

The Role of Flavonoids as a Cardioprotective Strategy against Doxorubicin-Induced Cardiotoxicity: A Review
by: Rony Abdi Syahputra, et al.
Published: (2022-02-01)

Nebivolol effect on doxorubicin-induced cardiotoxicity in breast cancer
by: Cochera F, et al.
Published: (2018-07-01)

The role of hesperidin as a cardioprotective strategy against doxorubicin-induced cardiotoxicity: The antioxidant, anti-inflammatory, antiapoptotic, and cytoprotective potentials
by: Fawiziah K. Alharbi, et al.
Published: (2023-12-01)

Potential chemoprotective effects of active ingredients in Salvia miltiorrhiza on doxorubicin-induced cardiotoxicity: a systematic review of in vitro and in vivo studies
by: Qingqing Wang, et al.
Published: (2023-10-01)

Protective effect of coenzyme Q10 against doxorubicin-induced cardiotoxicity: Scoping review article
by: Al Qahtani Abdullah, et al.
Published: (2024-02-01)

Anthracycline-Induced Cardiotoxicity
by: Radomír Hrdina, et al.
Published: (2000-01-01)

Doxorubicin-induced cardiotoxicity and risk factors
by: Carl Belger, et al.
Published: (2024-02-01)

Cardioprotective potential of botanical agents against anthracycline-induced cardiotoxicity
by: Parisa Firoozbakhsh, et al.
Published: (2024-05-01)

Nerolidol Attenuates Oxidative Stress, Inflammation, and Apoptosis by Modulating Nrf2/MAPK Signaling Pathways in Doxorubicin-Induced Acute Cardiotoxicity in Rats
by: Seenipandi Arunachalam, et al.
Published: (2021-06-01)

Cardioprotective Strategies from Cardiotoxicity in Cancer Patients: A Comprehensive Review
by: Christos Kourek, et al.
Published: (2022-08-01)

Cardiotoxicity of doxorubicin – causes, prevention, prospects
by: Paweł Wesołowski, et al.
Published: (2022-11-01)

Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer
by: Ariane V.S. Macedo, MD, MSc, et al.
Published: (2019-09-01)

Prevention of Anthracycline-Induced Cardiotoxicity: The Good and Bad of Current and Alternative Therapies
by: Nonhlakanipho F. Sangweni, et al.
Published: (2022-06-01)

Biomarkers of chemotherapy-induced cardiotoxicity: toward precision prevention using extracellular vesicles
by: Brian B. Silver, et al.
Published: (2024-04-01)

Doxorubicin Cardiotoxicity: An Update Regarding the Mechanism of Toxicity and Mitigation Strategies of Bee Propolis
by: Hodhaifa Abdul Mohsin, et al.
Published: (2023-12-01)

Lipidomics application to explain acute cardiotoxicity induced by doxorubicin
by: Lubna Zuhair Abdul Karim, et al.
Published: (2019-12-01)

Dapagliflozin May Protect Against Doxorubicin-Induced Cardiotoxicity
by: Sebahat Ulusan, et al.
Published: (2023-05-01)

Cardiotoxicity of doxorubicin: Causes, diagnosis, consequences and possibilities of prevention
by: Radić Jelena P., et al.
Published: (2022-01-01)

Cardioprotective Strategies for Doxorubicin-induced Cardiotoxicity: Present and Future
by: A. M. Chaulin, et al.
Published: (2022-03-01)

Investigation of the efficacy of tyrosol on doxorubicin-induced acute cardiotoxicity in rats
by: Mustafa Cellat, et al.
Published: (2022-09-01)

Effects of Carnosine on the Toxicity of Doxorubicin in Rabbits and Mice
by: Zieba Remigiusz, et al.
Published: (2003-08-01)

Effect of pimobendan on cytokine levels in doxorubicin-induced cardiotoxicity
by: Burak Dik, et al.

Diastolic disorder inherent to doxorubicin cardiotoxicity
by: Lilia Tacu, et al.
Published: (2021-10-01)

Demystifying the Relationship Between Metformin, AMPK, and Doxorubicin Cardiotoxicity
by: Manrose Singh, et al.
Published: (2022-01-01)

CARDIOPROTECTIVE EFFECT OF TUMOR NECROSIS FACTOR ALPHA ANTAGONIST IN DOXORUBICIN MYOCARD TOXICITY
by: M. I. Popovich, et al.
Published: (2018-02-01)

Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine
by: Irwin K. Cheah, et al.
Published: (2023-01-01)

The Role of Angiotensin‐Converting Enzyme Inhibitors and β‐Blockers in Primary Prevention of Cardiac Dysfunction in Breast Cancer Patients
by: Sherry‐Ann Brown, et al.
Published: (2020-01-01)

Mitophagy in Doxorubicin-Induced Cardiotoxicity: Insights into Molecular Biology and Novel Therapeutic Strategies
by: Heng Zhang, et al.
Published: (2024-12-01)

Cardioprotective Effect of Grape Seed Extract on Chronic Doxorubicin-Induced Cardiac Toxicity in Wistar Rats
by: Nasser Razmaraii, et al.
Published: (2016-09-01)

Prediction of doxorubicin cardiotoxicity by early detection of subclinical right ventricular dysfunction
by: Maria Isabel Camara Planek, et al.
Published: (2020-07-01)

A comprehensive review on the effects of sex hormones on chemotherapy-induced cardiotoxicity: are they lucrative or unprofitable?
by: Golnaz Kheradkhah, et al.
Published: (2024-12-01)

Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy
by: Mária Lódi, et al.
Published: (2019-07-01)

Anthracycline-induced cardiotoxicity – primary preventive options. An overview
by: S. Slavcheva
Published: (2024-05-01)

Review on the Role of Epigenetic Modifications in Doxorubicin-Induced Cardiotoxicity
by: Himani Kumari, et al.
Published: (2020-05-01)

The role of doxorubicin in the formation of cardiotoxicity is a consensus statement. Part II. Cardiotoxicity of doxorubicin unrelated to myocytes and cardioprotection strategy (review)
by: D. A. Andreev, et al.
Published: (2024-09-01)

Anti-apoptotic effects of minocycline on doxorubicin-induced cardiotoxicity in male Wistar rats
by: Hossein Piri, et al.
Published: (2023-12-01)

Oxymatrine Ameliorates Doxorubicin-Induced Cardiotoxicity in Rats
by: Yan-Yan Zhang, et al.
Published: (2017-09-01)

Taraxacum Officinale (Dandelion) Roots Extract Mitigates Doxorubicin-Induced HematoCardiotoxicity in Male Albino Rats
by: Dina R. S. Gad El-Karim
Published: (2019-12-01)

Pyridoxamine Limits Cardiac Dysfunction in a Rat Model of Doxorubicin-Induced Cardiotoxicity
by: Sibren Haesen, et al.
Published: (2024-01-01)

Cardioprotective potential of protocatechuic acid against doxorubicin-induced cardiotoxicity in rats
by: Leila Safaeian, et al.
Published: (2025-01-01)